Unexpected findings have implications for anti-obesity therapies.
Neurons hum at different frequencies to tell the brain which memories it should store.
The study showed that skin biopsies can be used to detect elevated levels of abnormal proteins found in the two diseases.
Three Austrians have replaced injured hands with bionic ones that they can control using nerves and muscles transplanted into their arms from their legs.
New technologies will help the field of telemedicine drastically grow this year.
Researchers have identified a previously unknown effect of vitamin A in human embryonic development.
Transcription, the process in which genetic information from DNA is copied into RNA to produce proteins, requires many pieces coming together.
For years, parents of babies who seem likely to develop a peanut allergy have gone to extremes to keep them away from peanut-based foods.
The Atlantic’s Olga Khazan wrote a new feature for the magazine examining the future of contraception.
The World Health Organization said Friday it has approved a quick test for Ebola that will dramatically cut the time it takes to determine - with reasonable accuracy - whether someone is infected with the deadly virus.
More hospitals and doctors are starting to use data from fitness trackers and health apps to help treat patients. But they are moving cautiously. The technology has a lot of potential, but there are key challenges to work out...
Scientists are interested in using gels to deliver drugs because they can be molded into specific shapes and designed to release their payload over a specified time period. However, current versions aren’t always practical because must be implanted surgically.
Hundreds of products are being pulled from store shelves after traces of peanut were found in cumin spice - a life-threatening danger to some people with peanut allergies.
Contaminated medical instruments are suspected in a "superbug" outbreak at a Los Angeles hospital that has infected at least seven patients, two of whom died. More than 170 others may have been exposed to the antibiotic-resistant bacteria.
A new study conducted by a researcher at the George Washington University suggests that the right hemisphere of the brain may be able to assist a damaged left hemisphere in protecting visual attention after a stroke.
The pathological process amyloidosis, in which misfolded proteins (amyloids) form insoluble fibril deposits, occurs in many diseases, including Alzheimer disease (AD) and type 2 diabetes mellitus (T2D).
Research suggests that fetal exposure to chemicals or drugs can cause neurological problems. Babies whose mothers take the epilepsy drug valporic acid (VPA) during pregnancy, for example, appear to have an elevated risk of developing an autism spectrum disorder.
Running hard may be as bad for your longevity as being a couch potato, says a recent study—one that should be taken with a grain of salt (hold the butter), say some critics. The study, in a recent Journal of the American College of Cardiology, examined 5,048 healthy people enrolled in the Copenhagen City Heart Study. For 12 years, 1,098 healthy joggers and 413 healthy, but sedentary non-joggers were followed.
This new insight about Broca’s area, which is located in the frontal cortex above and behind the left eye, could ultimately benefit the treatment of language impairments due to stroke, epilepsy and brain injuries.
Researchers have found that a compound produced by the body when dieting or fasting can block a part of the immune system involved in several inflammatory disorders such as type 2 diabetes, atherosclerosis, and Alzheimer’s disease.
Global health organizations said Tuesday that AIDS is now the leading cause of death for adolescents in Africa, and the second leading cause of death among adolescents globally.
The Atlantic's James Hamblin explores how our obsession with smartphones could stifle creative impulses.
The device goes beyond cochlear implants that have brought hearing to many deaf children but that don't work for tots who lack their hearing nerve.
Findings advance efforts to identify who would benefit from more aggressive therapy at earliest stages.
Australia is funding a three-year, 2.3 million Australian dollar ($1.8 million) project that will aid snakebite victims in Myanmar by upgrading care facilities and the quality and availability of antivenom.